Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07066085 · ClinicalTrials.gov registry record · Early Phase 1
Serial Blood Count Study
A Early Phase 1 study of Neutropenia and Congenital Neutropenia, sponsored by University of Washington.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT07066085: Recruiting Early Phase 1 study of Neutropenia and Congenital Neutropenia, sponsored by University of Washington.
NCT07066085 is a Early Phase 1 study of Neutropenia and Congenital Neutropenia that is actively recruiting participants, run by University of Washington. The registered enrollment target is 20 participants, below the 76-participant average among 12 other Neutropenia trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07066085, a Early Phase 1 study of Neutropenia and Congenital Neutropenia, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the Serial Blood Count Study is to determine the utility of home monitoring of white blood cell (WBC) and absolute neutrophil counts (ANC) to diagnose cyclic neutropenia and distinguish between cyclic and severe congenital neutropenia (SCN). A new home monitoring device called Athelas One was granted an FDA 510K Class 2 clearance for evaluation of white blood count (WBC) and absolute neutrophil count (ANC). The investigators believe this device provides a unique and extremely valuable opportunity to for diagnosis of these diseases.
Conditions Studied
Interventions
- DEVICE Serial Blood Count Study
- DEVICE Athelas Home device
Study Locations (1)
Washington
- University of Washington Medical Center - Montlake - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-10-17 |
| Est. Completion | 2025-12-01 |
| Phase | Early Phase 1 |
What NCT07066085 shows while recruiting
NCT07066085 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 76-participant average among 12 other Neutropenia trials with a reported enrollment target (74% lower).
The record links to 3 conditions, with Neutropenia appearing as the primary indexed condition, and to 2 interventions - of which Serial Blood Count Study is the first listed.
NCT07066085 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT07066085 about?
NCT07066085 is a clinical study titled "Serial Blood Count Study". The objective of the Serial Blood Count Study is to determine the utility of home monitoring of white blood cell (WBC) and absolute neutrophil counts (ANC) to diagnose cyclic neutropenia and distinguish between cyclic and severe congenital neutropenia (SCN). A new home monitoring device called Athel...
What is the current status of trial NCT07066085?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2024-10-17. Estimated completion is 2025-12-01.
What conditions does trial NCT07066085 study?
This clinical trial studies the following conditions: Neutropenia, Congenital Neutropenia, Cyclic Neutropenia.
What interventions are being tested in trial NCT07066085?
The interventions under investigation include: Serial Blood Count Study (DEVICE), Athelas Home device (DEVICE).
Who is sponsoring clinical trial NCT07066085?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07066085 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neutropenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07066085's enrollment target sits among peer trials
20 10th of 12 higher than 2 of 12 other Neutropenia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Neutropenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia
RECRUITING · Phase 2
-
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
RECRUITING · Phase 1
-
Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients
RECRUITING · Phase 4
-
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
RECRUITING · Phase 3
-
Luspatercept for Clonal Cytopenias of Uncertain Significance
RECRUITING · Phase 2
-
Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
- NCT01630850 · 20 participants · NA
Islet Transplantation in Patients With "Brittle" Type I Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI